Washington, DC: The Capitol was rocked with controversy yesterday afternoon as a faux fist fight broke out between two long-time Republican political allies, Majority Whip Steve Scalise and Vice-Chairman of the Veterans Affairs Committee, Gus Bilirakis. The source of the conflict—a good old fashioned football rivalry.
Washington, DC: As Vice-Chairman of the House Veterans Affairs Committee, Congressman Bilirakis has been actively involved in directing resources to end homelessness within the Veterans’ community for many years.
Washington, DC: As we prepare to recognize International Overdose Awareness Day tomorrow, Congressman Gus Bilirakis is pleased to announce the success of his recent efforts to increase funding for the Drug Free Communities program, and that his advocacy on behalf of a local Drug Prevention Coalition’s application for continued federal funding helped secure $125,000 for Pasco C
Washington, DC: Congressman Gus Bilirakis has been working to reduce the cost of prescription drugs for several years. He successfully authored multiple provisions within H.R. 2430, which was signed into law last August. One of his provisions created an expedited approval process for generic drugs when no competitor exists on the market. The U.S.
-Making it the 8th Provision Authored by Bilirakis to Become Law Since January of 2017-
Washington, DC: The Lower Costs Through Competition Act, authored by Congressman Gus Bilirakis and signed into law last year, is already proving effective in achieving its primary goal of lowering the price of prescription drugs.
Press Conference- August 1st- 10:30 a.m. - Local Veterans who are suffering from similar illnesses after being exposed to toxins during their service discuss how new bill filed by Congressman Bilirakis will help them.
Washington, DC: Congressman Bilirakis enjoyed the privilege of leading a meaningful discussion on the House Floor about the partnership between the U.S.
Washington, DC: Today, Representative Gus Bilirakis filed the Promoting Resource Officers Together for Exceptionally Critical Targets with